Business Context and Reporting Period
Company: ICU Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 20, 2026
Reporting Period: The filing reports on an event occurring on February 20, 2026, regarding an amendment to an executive plan effective December 31, 2025.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing discloses a material change to the Company's Executive Severance Plan:
- Action: The Compensation Committee adopted an amendment to the Executive Severance Plan.
- Effective Date: December 31, 2025.
- Change: The expiration date of the plan has been extended by three years to December 31, 2028.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly limited to the administrative amendment of the severance plan.
Investor Verification Checklist
- Verify the full text of the "Third Amendment to ICU Medical, Inc. Executive Severance Plan" filed as Exhibit 10.1 to understand specific terms of the extension.
- Confirm the impact of the plan extension on future compensation liabilities, if disclosed in subsequent filings.
- Note that this 8-K does not provide updated financial results; refer to the most recent 10-K or 10-Q for financial metrics.